Ординатура / Офтальмология / Английские материалы / Retinal and Vitreoretinal Diseases and Surgery_Boyd, Cortez, Sabates_2010
.pdf
Retinal Complications After Refractive Surgery
503
The basic LASIK procedure is based upon concepts and patients operated on by Barraquer.36 During the procedure, a lamellar corneal flap must be made to allow intrastromal ablation by the excimer laser beam. In order to obtain a consistent flap of the optimal thickness, the cornea is stabilized by a suction ring which is placed just behind the limbus and which sucks the anterior segment into a vacuum device firming the eye and the cornea. This device, the suction ring, has not changed in basic principle in the last 35 years. The following sequence of events might occur during the LASIK procedure. When the suction ring induces an increase in IOP (65 mmHg) and after that it is suddenly released, the anterior segment is rapidly drawn into a vacuum chamber with it’s shape changed rapidly, and all structures posterior to the suction ring are also compressed and decompressed in sequence. This type of “trauma” is in some ways analogous to what happens in a closed eye injury37-38 (“closed-suction injury”). A mechanism for development of peripheral retinal tears or macular disease could be anterior-posterior compression and expansion. The eye elongates along the anterior-posterior axis and the diameter of the globe may increase. At the same time, because the eye is a closed system, the eye is constricted in the equatorial plane (Figure 7A). As the anterior segment is drawn into a vacuum, the lens may be displaced forward along with the anterior hyaloid. This might accelerate vitreous detachment or cause traction at the vitreous base. When the suction suddenly is released, decompression leads to a dynamic overshoot with equatorial expansion and shortening in the anterior-posterior dimension (Figure 7B). These events may cause acute vitreo-retinal traction at the vitreous base and posterior pole.
Lens displacement could be responsible for cases of cataracts after LASIK. During compression there is traction posteriorly that may be responsible for the anecdotal reports of macular holes and macular hemorrhages. It is possible that there is deformation and traction near the vitreous base, which lies just posterior to the suction ring, this can be a cause of retinal breaks. We have measured the marks left immediately after the suction ring is applied in the sclera and its posterior border is at a mean of 4-mm posterior to the limbus. The elevation in IOP as well as the potential for deformation of the globe in the macula might also lead to exacerbation of macular pathology that can be present in high myopes such as defects in Bruch’s membrane (lacquer cracks).
Another potential source of damage to the vitreous and retina is from the pulsed energy applied to the cornea (Figure 7C). The excimer laser light ablates tissue; energy is released anteriorly as a plume of ablated tissue and is thrown into the air in front of the cornea. In addition, it has been reported that particulate mater was ejected from the cornea for up to 18 inches. Certainly such a powerful force might also be associated with backwards force into the vitreous. Hahn et al showed that most of the ablation particles seen to be launched in the air are water spherules. The particle diameter is 100-800 microns.39 Posteriorly, energy is transmitted in the form of a shockwave on the order of 10 atmospheres of pressure (Seiler and Krueger, unpublished observations). The effect of shockwaves and posteriorly-radiated energy on the vitreous integrity is unknown.
The incidence of vitreo-retinal pathology after LASIK in our studies was 0.06% (annual incidence 0.02%).24 This number is much
Retinal andVitreoretinal Diseases and Surgery
504
lower than the incidence of RRD in myopes in general.32 This finding may be explained by the fact that refractive surgery patients in the institutions involved underwent preoperative examinationsincludingaverythoroughdilated indirect funduscopy with scleral depression and treatment of any peripheral retinal lesion predisposing for the development of a RRD before LASIK. In this study extensive lattice degeneration, flap tears, atrophic holes, and retinal tufts were prophylactically treated regardless of symptoms. Such indication is justified by the fact that vitreo-retinal surgery causes changes in corneal shape thus damaging the refractive surgeon’s results as demonstrated by Azar-Arevalo and Arevalo.40 We suggest that cryopexy, argon laser retinopexy, pneumatic retinopexy or small-guage (25 or 23-gauge) vitrectomy without a scleral band be performed when appropriate because they tend not to change the shape or length of the globe. Another option in case of scleral buckling procedures is to remove the exoplants early, as suggested by Rodriguez and Camacho6, after being sure that all breaks have sealed and that no retinal detachment is present anywhere in the fundus.
We cannot determine whether treatment prophylactically is indicated. At the current time it is not possible to scientifically determine whether peripheral retinal lesions should be treated in a way different from standard practice just because a patient is to undergo LASIK. Mostpractitionerssuggestthatpatients scheduled for LASIK be carefully examined with indirect ophthalmoscopy and scleral depression under pupillary dilatation to detect any myopic peripheral lesion that requires
treatment before LASIK is performed. One could argue that this is prudent in myopes whether or not they undergo LASIK; given the potential of the procedure to exacerbate pre-existing pathology, it might be wise to treat such pathology more aggressively.
Another important factor to take into consideration when we evaluate our state of knowledge in this area is duration of follow up. It is reasonable to expect that the incidence of RRD in the initial cohort of patients that had LASIK will rise with time. It is possible that LASIK induced trauma might accelerate vitreous liquefaction and that over the years these patients might have a higher incidence of retinal detachments and other vitreo-retinal problems. It is equally likely that with the current practice patterns, we ophthalmologist would be unaware of this.
Macular diseases may be a relative contraindication to LASIK. Patients with high myopia and lacquer cracks in the macula are at high risk to develop macular hemorrhage or CNV after the intraocular pressure is raised with the suction ring during the procedure. Patients with angioid streaks and traumatic choroidal ruptures are in the same category of risk. Stage 1 macular holes may progress due to traction in the posterior pole during LASIK. In addition, eyes that are at risk of needing vitreoretinal surgery in the future have a relative contraindication to LASIK. On the other hand, in eyes with stable macular disease (scars), LASIK may be performed depending on the refractive surgeon’s criteria if the patient is aware and accepts his visual acuity limitations.
Retinal Complications After Refractive Surgery
Summary
Serious complications after LASIK are infrequent. It is very important to inform patients that LASIK only corrects the refractive aspect of myopia. Vitreoretinal complications in these eyes will occur and only careful and large prospective studies in patients can determine if the procedure exacerbates myopic pathology. Such studies will need to be performed using careful prospective examinations including determination of risk factors, echography of the vitreous, indirect ophthalmoscopy and scleral depression and possible photography and angiography of the macula region to determine whether the LASIK procedure itself can exacerbate pathologic changes in the myopic eye. In addition, our studies show that results may be not as good as expected after RRD surgery. Reasons for poor VA include the development of epiretinal membrane, proliferative vitreo-retinopathy, chronicity of RRD, new retinal breaks, and cataract formation. Final VA may be limited by myopic degeneration, amblyopia, or delayed referral to a vitreoretinal specialist.
References
1.Sperduto RD, Seigel D, Roberts J, Rowland M. Prevalence of myopia in the United States. Arch Ophthalmol 1983;101:405-7.
2.McCarty CA, Livingston PM, Taylor HR. Prevalence of myopia in adults: implications for refractive surgeons. J Refract Surg 1997;13:229-34.
3.Hofman RF, Starling JC, Hovland KR. Case report: retinal detachment after radial keratotomy surgery. J Refract Surg 1985;1:226.
4.Sanders DR, Hofman RF, Salz JJ. Refractive Corneal Surgery. Slack Inc, Thorofare, NJ: 1986;388.
505
5.Feldman RM, Crapotta JA, Feldman ST, Goldbaum MH. Retinal detachment following radial and astigmatic keratotomy. Refract Corneal Surg 1991;7:252-3.
6.Rodriguez A, Camacho H. Retinal detachment after refractive surgery for myopia. Retina 1992;12:S46-50.
7.Rodriguez A, Gutierrez E, Alvira G. Complications of clear lens extraction in axial myopia. Arch Ophthalmol 1987;105:1522-3.
8.Barraquer C, Cavelier C, Mejia LF. Incidence of retinal detachment following clear-lens extraction in myopic patients: Retrospective analysis. Arch Ophthalmol 1994;112:336-9.
9.Ripandelli G, Billi B, Fedeli R, Stirpe M. Retinal detachment after clear lens extraction in 41 eyes with high axial myopia. Retina 1996;16:3-6.
10.Ruiz-Moreno JM, Alio JL, Perez-Santonja JJ, de la Hoz F. Retinal detachment in phakic eyes with anterior chamber intraocular lenses to correct severe myopia. Am J Ophthalmol 1999;127:270-5.
11.Pallikaris IG, Papatzanaki ME, Siganos DS. A corneal flap technique for laser in situ keratomileusis. Arch Ophthalmol 1991;109:1699-702.
12.Zaldivar R, Davidorf JM, Oscherow S. Laser in situ keratomileusis for myopia from -5.50 to -11.50 diopters with astigmatism. J Refract Surg 1998;14:1925.
13.Pallikaris IG, Siganos DS. Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg 1994; 10:498-510.
14.Guell JL, Muller A. Laser in situ keratomileusis (LASIK) for myopia from -7 to -18 diopters. J Refract Surg 1996;12:222-228.
15.Perez-Santonja JJ, Sakla HF, Abad JL, Zorraquino A, Esteban J, Alio JL. Nocardial keratitis after laser in situ keratomileusis. J Refract Surg 1997;13:314-317.
16.Mulhern MG, Condon PI, O’Keefe M. Endophthalmitis after astigmatic myopic laser in situ keratomileusis. J Cataract Refract Surg 1997;23:948-950.
17.Stulting RD, Carr JD, Thompson KP, Waring GO 3rd, Wiley WM, Walker JG. Complications of laser in situ keratomileusis for the correction of myopia. Ophthalmology 1999;106:13-20.
Retinal andVitreoretinal Diseases and Surgery
506
18.Kim HM, Jung HR. Laser assisted in situ keratomi29. Ruiz-Moreno JM, Artola A, Ayala MJ, Claramonte P,
leusis for high myopia. Ophthalmic Surg Lasers 1996;27:508-11.
19.Luna JD, Reviglio VE, Juarez CP. Bilateral macular hemorrhage after laser in situ keratomileusis. Graefes Arch Clin Exp Ophthalmol 1999;237:611-3.
20.Ozdamar A, Aras C, Sener B, Oncel M, Karacorlu M. Bilateral retinal detachment associated with giant retinal tear after laser-assisted in situ keratomileusis. Retina 1998;18:176-7.
21.Ruiz-Moreno JM, Perez-Santoja JJ, Alio JL. Retinal detachment in myopic eyes after laser in situ keratomileusis. Am J Ophthalmol 1999;128:588-594.
Alio JL. Choroidal neovascularization in myopic eyes after photorefractive keratectomy. J Cataract Refract Surg 2000;26:1492-5.
30.Arevalo JF, Mendoza AJ, Velez-Vazquez W, Rodriguez FJ, Rodriguez A, Rosales-Meneses JL, Yepez JB, Ramirez E, Dessouki A, Chan CK, Mittra RA, Ramsay RC, Garcia RA, Ruiz-Moreno JM. Fullthickness macular hole after LASIK for the correction of myopia. Ophthalmology 2005;112:1207-12.
31.Chaudhry NA, Smiddy WE. Displacement of corneal cap during vitrectomy in a post-LASIK eye. Retina 1998;18:554-5.
22.Aras C, Ozdamar A, Karacorlu M, Sener B, Bahce32. Schepens CL. Retinal Detachment and Allied
cioglu H. Retinal detachment following laser in situ keratomileusis.OphthalmicSurgLasers2000;31:121-5.
23.Farah ME, Hofling-Lima AL, Nascimento E. Early rhegmatogenous retinal detachment following laser in situ keratomileusis for high myopia. J Refract Surg 2000;16:739-43.
24.Arevalo JF, Ramirez E, Suarez E, Morales-Stopello J, Cortez R, Ramirez G, Antzoulatos G, Tugues J, Rodriguez J, Fuenmayor-Rivera D. Incidence of vitreo-retinal pathologic conditions 24 months after laser-assisted in situ keratomileusis (LASIK). Ophthalmology 2000;107:258-262.
25.Arevalo JF, Ramirez E, Suarez E, Antzoulatos G, Torres F, Cortez R, Morales-Stopello J, Ramirez G. Retinal Detachments after Laser-assisted In Situ Keratomileusis (LASIK) for the Correction of Myopia. Retina 2000;20:338-341.
Diseases. Philadelphia, PA: WB Saunders, 1983;47. [ibid]
33.Ogawa A, Tanaka M. The relationship between refractive errors and retinal detachment-analysis of 1,116 retinal detachment cases. Jpn J Ophthalmol 1988;32:310-5.
34.Curtin BJ. The myopias: basic and clinical management. Philadelphia: Harper & Row, 1985:337-9. [ibid]
35.The Eye Disease Case-Control Study Group. Risk factors for idiopathic rhegmatogenous retinal detachment. Am J Epidemiol 1993;137:749-57.
36.Barraquer JI. [Keratomileusis for the Correction of Myopia]. Arch Soc Am Oftalmol Optom 1964;5:27:48.
37.Weidenthal DT, Schepens CL. Peripheral fundus changes associated with ocular contusion. Am J Ophthalmol 1966;62:465.
26.Kim HM, Jung HR. Laser assisted in situ keratomi38. Benson WE. The effects of blunt trauma on the
leusis for high myopia. Ophthalmic Surg Lasers 1996;27:508-11.
posterior segment of the eye. Trans Pa Acad Ophthalmol Otolaryngol 1984;37:26.
27.Luna JD, Reviglio VE, Juarez CP. Bilateral macu39. Hahn DW, Ediger MN, Pettit GH. Dynamics of
lar hemorrhage after laser in situ keratomileusis. Graefes Arch Clin Exp Ophthalmol 1999;237:611-3.
28.Ruiz-MorenoJM,Perez-SantonjaJJ,AlioJL.Choroidal neovascularizationinmyopiceyesafterlaser-assisted in situ keratomileusis. Retina 2001;21:115-20.
ablation plume particles generated during excimer laser corneal ablation. Lasers Surg Med 1995;16:384-9.
40.Azar-Arevalo O, Arevalo JF. Corneal Topography Changes after Vitreo-retinal Surgery. Ophthalmic Surg Lasers 2001;32:168-172.









31
Management
of Intraocular Hemorrhage and Other Complications
George B. Peters III, M.D., M.B.A.
George K. Asdourian, M.D.
Linda Stein, M.S.
Shalesh Kaushal, M.D., Ph.D.
Introduction
This chapter discusses intraocular hemorrhage of interest to the retina specialist and posterior-segment surgeon, with a focus on vitreous hemorrhage. Issues related to hyphema and other anterior segment hemorrhages will not be discussed. Additionally, small hemorrhages within the retina, most commonly seen with diabetes mellitus and systemic hypertension as well as a myriad of other less commonly associated disorders, will not be addressed, although technically these do qualify as intraocular hemorrhages. Subretinal and suprachoroidal hemorrhages, which are relatively uncommon, also are not covered in this chapter.
A vitreous hemorrhage is one of the most common disorders presenting to a retina practice. Its underlying etiology is variable although most often related to proliferative
diabetic retinopathy. Other pathologies in the differential diagnosis for vitreous hemorrhage include vascular occlusive disease, retinal breaks or tears, a posterior vitreous detachment, exudative macular degeneration, as well as rare neoplasia. Additional uncommon causes of vitreous hemorrhage include trauma, radiation retinopathy, retinopathies secondary to hemoglobinopathies and inflammation. Table 1 lists the etiologies of vitreous hemorrhages, in order of relative incidence.
First, we will discuss the management of patients with vitreous hemorrhage and then discuss the underlying disease states that are the primary pathologies responsible for vitreous hemorrhages. Although this order of presentation may seem backwards, often vitreous hemorrhage requires management without certitude of the underlying pathology responsible, which may be unclear or presumptive (e.g., in the case of diabetes mellitus). Fortunately, the clear media of
Retinal andVitreoretinal Diseases and Surgery
508
Table 1
Etiology of Vitreous Hemorrhage by Mechanism and Relative Incidence
Incidence
i- Retinal Neovascularization Diabetic Retinopathy
Other Retinal Vascular Occlusive Disease
Central Retinal Vein Occlusion
Branch Retinal Vein Occlusion
Central Retinal Artery Occlusion
Branch Retinal Arteriole Occlusion Retinopathy associated with Hemoglobinopathy Peripheral Vascular Occlusive Disease
Vasculitis (Phlebitis, Arteritis or Both) Posterior or Intermediate Uveitis
Radiation Retinopathy
iiPathology of the Vitreo-Retinal Interface Peripheral Retinal Tears/Breaks Posterior Vitreous Detachment
iiiChoroidal Neovascularization
Exudative Age-related Macular Degeneration Peripheral Choroidal Neovascularization
Choroidal Neovascularization from Other Disorders ivNeoplasia
v- Trauma
intraocular tissues allows the ophthalmologist to often see intraocular pathology directly. Thus ophthalmologists commonly are able to eliminate (or mitigate) the uncertainty of diagnosis much of the time. The patient history, diagnostic testing, and to a lesser extent the physical examination are more critical in managing vitreous hemorrhages than for other ocular conditions that can be visualized directly.
Patient History
Management of a vitreous hemorrhage generally requires more emphasis on the
patient history than in patients with other retinal diseases. For vitreous hemorrhages, the time from onset of symptoms to presentation is typically a matter of hours or days, since hemorrhages are typically, though not exclusively, dramatically symptomatic. With large vitreous hemorrhages, symptoms typically occur suddenly with significant loss of vision; these hemorrhages also typically obscure the view of the examiner as well as the patient. With smaller vitreous hemorrhages, symptoms of black floaters can occur which commonly appear to rise from inferior to superior visual space, secondary to the inverted real image projected on the
Management of Intraocular Hemorrhage and Other Complications
509
retina. Movement of floaters may be reported as resembling air bubbles underwater as in an aquarium, owing to the blood’s circuitous track in the irregularly syneretic vitreous body. Some patients report symptoms as a myriad of small objects obscuring vision in the affected eye, or looking through a screen door or window (Figure 1).
Pain is universally absent with the exception of patients for whom the etiology is trauma, which would be generally obvious from the history. A history of any known ophthalmic disease should be elicited. Review of the patient’s medical history may include a pre-existing ocular disease such as recent ophthalmic surgery, diabetic retinopathy or
ocular neoplasm. Often, however, no such history is reported, with the common exception of diabetes mellitus. In much of the industrialized world, undiagnosed diabetes mellitus is relatively unlikely if effective widespread screening has been conducted. However, in the United States routine screening for diabetes mellitus is not extensive due to high costs, and in much of the developing world screening is generally unavailable. In any case, eliciting a history of diabetes mellitus specifically is critical. If a patient presenting with a vitreous hemorrhage with no known predisposing risk factor responds that he or she does not have diabetes mellitus, followup questioning regarding a family history of diabetes mellitus and the date and method
Figure 1. Moderate Vitreous Hemorrhage. Vitreous hemorrhages in reabsorption phase may cloud the vision centrally or appear as floaters that move around, affecting vision.
Retinal andVitreoretinal Diseases and Surgery
510
of the patient’s most recent screening test is important (Figure 2). Such tests can include a routine urinalysis or serum glucose test. Comprehensive questioning regarding routine medications, other health conditions, family history and social circumstance is necessary in essentially all patients; in addition, specific clues regarding thalassemia or sickle cell disease or trait can be particularly helpful in patients with vitreous hemorrhage without an underlying likely etiology. A history of a malignancy or thyroid eye disease may uncover a history of radiation exposure. Multiple risk factors for cardiovascular dis-
ease will increase the likelihood of commonly encountered diagnoses of vascular occlusive disease.
Patients with vitreous hemorrhages who are asymptomatic (and therefore visit an eyecare provider much later than symptomatic patients) typically have underlying ocular pathology. Encountering patients with asymptomatic long-standing vitreous hemorrhages is unusual except for patients with poor acuity associated with a long history of an underlying risk factor for vitreous hemorrhage such as diabetic retinopathy (Figure 3).
Figure 2. Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy and NVD. Even if the patient ignores the possibility of having the disease, it is important to evaluate the pathology, especially if the anterior segment is normal or not related to the reduction in vision.
Management of Intraocular Hemorrhage and Other Complications
511
Figure 3. Proliferative Diabetic Retinopathy and NVD. A typical case were the macula still was not affected and the patient has not notice the severity of its retinal and visual problem.
Physical Examination
A direct or partial view of the underlying cause of a vitreous hemorrhage can in some circumstances be seen on physical examination. This view is usually available in less severe cases, when the patient may be asymptomatic. Examination alone may establish the diagnosis. Examination usually involves an indirect ophthalmoscope, which can be used with scleral indentation to obtain a kinetic examination of the peripheral fundus and observe clues regarding the presence of a peripheral break or tear if not observable
directly (Figure 4). Caution in this regard is necessary as the lamellar nature of the partially synergetic, gelatinous vitreous can commonly create, in a cleft of syneretic vitreous, the illusion of a break when none actually exists. Alternatively, the slit lamp (biomicroscope) may be used with various lenses capable of providing a highly magnified view of the retina to observe directly the culpable retinal or choroidal neovascularization, for example.
Commonly, however, on examination there is no view of the posterior segment other than that of the hemorrhage. The
Retinal andVitreoretinal Diseases and Surgery
512
Figure 4: Method for Localizing and Marking Retinal Tears. This internal/external conceptual illustration shows how the site is marked on the external sclera that corresponds to the internal position of a retinal break. The indirect ophthalmoscope (O) is used for visualization while the sclera overlying the break is depressed (arrow-A). A section of sclera (S) is shown removed to reveal a cross section of the scleral depression made directly external to the retinal tear (T). The corresponding surgeon’ s view of this depression is seen through the indirect ophthalmoscope lens (O). (Art from Jaypee - Highlights Medical Publishers).
hemorrhage typically has a red appearance in the acute phase, and this red color may be preserved in longstanding hemorrhages as well (Figure 5). In long-term hemorrhages, the hemorrhage may appear white or gray after hemoglobin degradation. Often this phenomenon is noted in the inferior vitreous as gravity consolidates the hemorrhage. It may be more difficult to make the diagnosis of vitreous hemorrhage in patients with longstanding disease, and the differential diagnosis in these circumstances may expand to include posterior segment uveitities and neoplasia. Typically blood in the vitreous cavity is removed by macrophage digestion over time.
Patients may notice, and the ophthalmologist may observe on examination, that subtle abnormalities in the vitreous remain after the hemorrhage has cleared, but typically, the hemorrhages are entirely resorbed over time. The patient’s age and the degree of vitreous syneresis influence the time needed for resorption. Other factors which affect the speed of resolution (also related to the extent of syneresis) are refractive error (i.e., vitreous volume), previous vitreous surgery or procedures, and the presence of comorbid inflammation. The etiology of the inflammation also must be considered as it may be secondary to the underlying etiology of
